Establishment of High Throughput SARS-CoV-2 Binding Antibody Immunoassay Capability and Testing of Human Serum Samples

Award Notice Posted

Solicitation number
75A50121P00015
Agency
Awarded
to Laboratories Nexelis Canada Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75A50121P00015 Federal contract award
Place of performance
Seattle WA 98119 USA

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

This Award Notice from the Department of Health and Human Services establishes a contract with Nexelis Laboratories Canada Inc. to provide high throughput multiplex MSD-ECL immunoassay services for COVID-19 testing of human serum samples from clinical trials of COVID-19 vaccines. The objectives are to establish this testing capability in compliance with Good Clinical Laboratory Practice and provide serologic data to support development of a vaccine correlate of protection. The contract was awarded for $802,318 on December 8, 2020 to meet these objectives.

Notice text

The objectives of this contract are: (1) Contractor to establish a high throughput multiplex MSD-ECL immunoassay for COVID-19 for use in testing of serum samples from human subjects enrolled in clinical trials of COVID-19 vaccines in compliance with Good Clinical Laboratory Practice (GCLP); and (2) Contractor to provide the USG with serologic data to support establishment of a correlate of protection to help facilitate expanded use of approved COVID-19 vaccines and accelerated approvals of additional vaccines.

Awarded contract 75A50121P00015 to NEXELIS LABORATORIES CANADA INC for 8023218.00 on 2020-12-08.

Files

File Type Posted
Class J and A Final 3.21.20.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login

GovTribe for Federal Contractors